Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix
Pfizer Inc. said two federal advisory panels have recommended removing the most serious warnings on its Chantix smoking cessation pill, clearing a major hurdle in the pharmaceutical giant ’s push to lessen concerns about using the medicine. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 14, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA panel recommends dropping serious warning on Pfizer's Chantix
(Reuters) - A serious warning on Pfizer Inc's quit smoking drug should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data on the controversial treatment. (Source: Reuters: Health)
Source: Reuters: Health - September 14, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
E-cigarettes 'help thousands successfully quit smoking'
Conclusion
Stopping smoking remains the best thing you can possibly do for your health. Anything that can help reduce the number of people who smoke is likely to have a good impact on health.
But although this study found e-cigarette use was linked to an increase in successful quit attempts, there are a number of things to be aware of:
Attempting to quit with e-cigarettes alone may not be as helpful as attempting to quit using an NHS stop smoking service. Getting support and help for a quit attempt is thought to increase your chances of success fourfold. You can use NHS services and e-cigarettes together if you wish. ...
Source: NHS News Feed - September 14, 2016 Category: Consumer Health News Tags: Lifestyle/exercise Medication Heart/lungs Cancer Source Type: news
FDA Reviewers Question Chantix/Zyban Safety Study
(MedPage Today) -- Inclusion criteria and data collection criticized (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 13, 2016 Category: Primary Care Source Type: news
FDA Questions Validity of Smoking Cessation Drug Research FDA Questions Validity of Smoking Cessation Drug Research
The FDA has raised concerns about a postmarketing study that examined adverse neuropsychiatric events associated with smoking cessation drugs varenicline and bupropion.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2016 Category: Consumer Health News Tags: Psychiatry News Source Type: news
FDA Questions Pfizer's Chantix Trial Data
The FDA says Pfizer ' s study of neuropsychiatric effects of its smoking cessation drug Chantix may have presented confusing data on adverse events, potentially biasing the research. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 13, 2016 Category: Pharmaceuticals Source Type: news
Morning Break: FDA on Chantix; Kids and Medicine; Failure to Improve
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 13, 2016 Category: Psychiatry Source Type: news
FDA staff flags concerns about Pfizer's quit-smoking drug study
(Reuters) - Pfizer Inc's trial data on Chantix, a drug to help people quit smoking, failed to impress U.S. Food and Drug Administration scientists, in a blow to the company's attempts to have a serious warning removed from the drug's label. (Source: Reuters: Health)
Source: Reuters: Health - September 12, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
Chantix (Varenicline) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 2, 2016 Category: Drugs & Pharmacology Source Type: news
FDA warning on drug for quitting smoking needs rethink, say researchers
Researchers from the University of Bristol have called for the USA Food and Drug Administration ’ s ‘ black box ’ warning for smoking cessation drug varenicline to be lifted. (Source: University of Bristol news)
Source: University of Bristol news - September 1, 2016 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, School of Social and Community Medicine, Institutes, Elizabeth Blackwell; Press Release Source Type: news
Quitting smoking during the second half of the menstrual cycle may help women kick the habit
Follow me on twitter @hricciot
Nearly every woman will acknowledge that her menstrual cycle affects her mood and behavior. An estimated 85% of women experience premenstrual syndrome one to two weeks before her period, which may include moodiness, anxiety, irritability, or food cravings along with physical symptoms such as bloating and breast tenderness. Studies suggest that women are more likely to engage in addictive behaviors, such as cigarette smoking, in the first half of the menstrual cycle, that is the time between the start of your period and ovulation. The underlying reason is thought to be that the hormone estradi...
Source: New Harvard Health Information - July 21, 2016 Category: Consumer Health News Authors: Hope Ricciotti, MD Tags: Addiction Behavioral Health Prevention Smoking cessation Women's Health Source Type: news
Some Tobacco-Cessation Treatments Better Than Others in Women (CME/CE)
(MedPage Today) -- Chantix especially helpful for female smokers (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 14, 2016 Category: Primary Care Source Type: news
Smoking cessation success linked to sex difference
Photo by ©Shutterstock.com/Pedro Bento
A meta-analysis of smoking cessation therapies, funded by the National Institute on Drug Abuse (NIDA), showed that clinicians should strongly consider varenicline as the first treatment option for women who are trying to quit smoking. Varenicline, a... (Source: NIDA News)
Source: NIDA News - July 10, 2016 Category: Addiction Tags: Tobacco, Treatment Research Source Type: news
What ’s the best way to quit smoking?
Smoking cigarettes contributes to almost 1 in 5 deaths. The top three smoking-related causes of death are cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease (COPD). In addition to these “top three,” smoking is also linked to a number of other cancers, an increased likelihood of getting more colds and infections, diabetes, osteoporosis and hip fractures, problems in pregnancy, difficulty with erections, stomach ulcers, gum disease, and the list goes on.
Quitting smoking can add years to your life. Though the earlier the better, it’s never too late to quit. The benefits of quitting are real,...
Source: New Harvard Health Information - July 8, 2016 Category: Consumer Health News Authors: Wynne Armand, MD Tags: Addiction Behavioral Health Lung disease Prevention Smoking cessation Source Type: news
What’s the best way to quit smoking?
Smoking cigarettes contributes to almost 1 in 5 deaths. The top three smoking-related causes of death are cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease (COPD). In addition to these “top three,” smoking is also linked to a number of other cancers, an increased likelihood of getting more colds and infections, diabetes, osteoporosis and hip fractures, problems in pregnancy, difficulty with erections, stomach ulcers, gum disease, and the list goes on.
Quitting smoking can add years to your life. Though the earlier the better, it’s never too late to quit. The benefits of quitting are real,...
Source: New Harvard Health Information - July 8, 2016 Category: Consumer Health News Authors: Wynne Armand, MD Tags: Addiction Behavioral Health Lung disease Prevention Smoking cessation Source Type: news
